Artur Płonowski

1.3k total citations
32 papers, 978 citations indexed

About

Artur Płonowski is a scholar working on Endocrinology, Diabetes and Metabolism, Oncology and Epidemiology. According to data from OpenAlex, Artur Płonowski has authored 32 papers receiving a total of 978 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Endocrinology, Diabetes and Metabolism, 11 papers in Oncology and 9 papers in Epidemiology. Recurrent topics in Artur Płonowski's work include Growth Hormone and Insulin-like Growth Factors (12 papers), Neuroendocrine Tumor Research Advances (9 papers) and Neuropeptides and Animal Physiology (8 papers). Artur Płonowski is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (12 papers), Neuroendocrine Tumor Research Advances (9 papers) and Neuropeptides and Animal Physiology (8 papers). Artur Płonowski collaborates with scholars based in United States, Japan and Poland. Artur Płonowski's co-authors include Andrew V. Schally, Gábor Halmos, Attila Nagy, József L. Varga, Kate Groot, Zoltán Rékási, Baodong Sun, Magdalena Krupa, Francine Hébert and Ana Maria Comaru‐Schally and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Artur Płonowski

32 papers receiving 957 citations

Peers

Countries citing papers authored by Artur Płonowski

Since Specialization

Citations

This map shows the geographic impact of Artur Płonowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Artur Płonowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Artur Płonowski more than expected).

Fields of papers citing papers by Artur Płonowski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Artur Płonowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Artur Płonowski. The network helps show where Artur Płonowski may publish in the future.

Co-authorship network of co-authors of Artur Płonowski

This figure shows the co-authorship network connecting the top 25 collaborators of Artur Płonowski. A scholar is included among the top collaborators of Artur Płonowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Artur Płonowski. Artur Płonowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	MetAP2 inhibition increases energy expenditure through direct action on brown adipocytes 2019 ·Journal of Biological Chemistry ·Huey-Jing Huang, (unknown), (unknown), James Bilakovics, Andrea Fanjul, Yoshinori Satomi, Artur Płonowski, Christopher J. Larson, (unknown)	7
2	Using Target Engagement Biomarkers to Predict Clinical Efficacy of MetAP2 Inhibitors 2019 ·Journal of Pharmacology and Experimental Therapeutics ·(unknown), (unknown), Huey-Jing Huang, Deepika Balakrishna, (unknown), James Bilakovics, Andrea Fanjul, (unknown), Artur Płonowski, (unknown), (unknown), Jacques Ermolieff, Zacharia S. Cheruvallath, Christopher M. McBride, Darian M. Bartkowski, (unknown), Alok S. Pachori, Christopher J. Larson	6
3	Chronic fractalkine administration improves glucose tolerance and pancreatic endocrine function 2018 ·Journal of Clinical Investigation ·Matthew Riopel, Jong Bae Seo, Gautam Bandyopadhyay, Pingping Li, Joshua Wollam, Heekyung Chung, Seung‐Ryoung Jung, Anne N. Murphy, Maria E. Wilson, Ron de Jong, Sanjay Patel, Deepika Balakrishna, James Bilakovics, Andrea Fanjul, Artur Płonowski, Duk‐Su Koh, Christopher J. Larson, Jerrold M. Olefsky, Yun Sok Lee	30
4	CX3CL1-Fc treatment prevents atherosclerosis in Ldlr KO mice 2018 ·Molecular Metabolism ·Matthew Riopel, Melanie Vassallo, Erik Ehinger, Jennifer Pattison, Karen Bowden, Holger Winkels, Maria E. Wilson, Ron de Jong, Sanjay Patel, Deepika Balakrishna, James Bilakovics, Andrea Fanjul, Artur Płonowski, Christopher J. Larson, Klaus Ley, Pedro Cabrales, Joseph L. Witztum, Jerrold M. Olefsky, Yun Sok Lee	25
5	Discovery of potent, reversible MetAP2 inhibitors via fragment based drug discovery and structure based drug design—Part 1 2016 ·Bioorganic & Medicinal Chemistry Letters ·Zacharia S. Cheruvallath, (unknown), Christopher M. McBride, (unknown), (unknown), (unknown), (unknown), Jun Feng, (unknown), J. David Lawson, Darin Vanderpool, Yiqin Wu, Douglas R. Dougan, Artur Płonowski, (unknown), Christopher J. Larson	12
6	Discovery of potent, reversible MetAP2 inhibitors via fragment based drug discovery and structure based drug design—Part 2 2016 ·Bioorganic & Medicinal Chemistry Letters ·Christopher M. McBride, Zacharia S. Cheruvallath, (unknown), (unknown), (unknown), J. David Lawson, Darin Vanderpool, Yiqin Wu, Douglas R. Dougan, Artur Płonowski, (unknown), Christopher J. Larson	18
7	Expression of growth hormone-releasing hormone (GHRH) and splice variants of GHRH receptors in human experimental prostate cancers 2002 ·Peptides ·Artur Płonowski, Andrew V. Schally, Rebeca Busto, Magdalena Krupa, József L. Varga, Gábor Halmos	42
8	Inhibition of in vivo proliferation of MDA-PCa-2b human prostate cancer by a targeted cytotoxic analog of luteinizing hormone-releasing hormone AN-207 2002 ·Cancer Letters ·Artur Płonowski, Andrew V. Schally, Attila Nagy, Kate Groot, Magdalena Krupa, Nora M. Navone, Christopher J. Logothetis	23
9	Inhibition of PC‐3 human prostate cancers by analogs of growth hormone‐releasing hormone (GH‐RH) endowed with vasoactive intestinal peptide (VIP) antagonistic activity 2002 ·International Journal of Cancer ·Artur Płonowski, József L. Varga, Andrew V. Schally, Magdalena Krupa, Kate Groot, Gábor Halmos	22
10	Inhibition of proliferation in human MNNG/HOS osteosarcoma and SK‐ES‐1 Ewing sarcoma cell lines in vitro and in vivo by antagonists of growth hormone‐releasing hormone 2002 ·Cancer ·(unknown), Andrew V. Schally, Artur Płonowski, József L. Varga, Kate Groot, Magdalena Krupa, Patricia Armatis	46
11	Regulation of prostate‐specific antigen (PSA) gene expression and release in LNCaP prostate cancer by antagonists of growth hormone‐releasing hormone and vasoactive intestinal peptide 2001 ·The Prostate ·Zoltán Rékási, Andrew V. Schally, Artur Płonowski, Tamás Czömpöly, Balázs Csernus, József L. Varga	21
12	Targeting of doxorubicin to ES-2 human ovarian cancers in nude mice by linking to an analog of luteinizing hormone-releasing hormone improves its effectiveness 2001 ·International Journal of Oncology ·José M. Arencibia, Andrew V. Schally, Magdalena Krupa, Ana M. Bajo, Attila Nagy, Károly Szepesházi, Artur Płonowski	23
13	Antiproliferative actions of growth hormone-releasing hormone antagonists on MiaPaCa-2 human pancreatic cancer cells involve cAMP independent pathways 2001 ·Peptides ·Zoltán Rékási, József L. Varga, Andrew V. Schally, Artur Płonowski, Gábor Halmos, Balázs Csernus, Patricia Armatis, Kate Groot	13
14	Inhibition of the UCI-107 human ovarian carcinoma cell line by a targeted cytotoxic analog of somatostatin, AN-238 2001 ·Cancer ·Artur Płonowski, Andrew V. Schally, Miklós Koppán, Attila Nagy, José M. Arencibia, Balázs Csernus, (unknown)	17
15	Inhibition of metastatic renal cell carcinomas expressing somatostatin receptors by a targeted cytotoxic analogue of somatostatin AN-238. 2000 ·PubMed ·Artur Płonowski, Andrew V. Schally, Attila Nagy, Hippokratis Kiaris, Francine Hébert, Gábor Halmos	37
16	Potentiation of the inhibitory effect of growth hormone-releasing hormone antagonists on PC-3 human prostate cancer by bombesin antagonists indicative of interference with both IGF and EGF pathways 2000 ·The Prostate ·Artur Płonowski, Andrew V. Schally, József L. Varga, Zoltán Rékási, Francine Hébert, Gábor Halmos, Kate Groot	58
17	in vivo inhibition of PC-3 human androgen-independent prostate cancer by a targeted cytotoxic bombesin analogue, AN-215 2000 ·International Journal of Cancer ·Artur Płonowski, Attila Nagy, Andrew V. Schally, Baodong Sun, Kate Groot, Gábor Halmos	53
18	Correlation between 21 amino acid endothelin, intrafollicular steroids and follicle size in stimulated cycles 1999 ·Human Reproduction ·Artur Płonowski, (unknown), (unknown), (unknown), B Baranowska	13
19	Are μ-opioid receptors involved in the control of endothelin-1 release from the pituitary gland in normal and dehydrated rats? 1997 ·Regulatory Peptides ·Artur Płonowski, (unknown), (unknown), B Baranowska, B Woźniewicz	4
20	Impaired response of atrial natriuretic peptide to acute water load in obesity and in anorexia nervosa 1995 ·European Journal of Endocrinology ·B Baranowska, Elżbieta Wasilewska-Dziubińska, (unknown), Artur Płonowski, Krzysztof Roguski	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact